Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2009 5
2010 1
2011 1
2012 1
2013 1
2014 1
2017 2
2019 1
2021 3
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Drug-binding databases.
Timmers LF, Pauli I, Caceres RA, de Azevedo WF Jr. Timmers LF, et al. Among authors: pauli i. Curr Drug Targets. 2008 Dec;9(12):1092-9. doi: 10.2174/138945008786949379. Curr Drug Targets. 2008. PMID: 19128220 Review.
Bioinformatics tools for screening of antiparasitic drugs.
de Azevedo WF Jr, Dias R, Timmers LF, Pauli I, Caceres RA, Soares MB. de Azevedo WF Jr, et al. Among authors: pauli i. Curr Drug Targets. 2009 Mar;10(3):232-9. doi: 10.2174/138945009787581122. Curr Drug Targets. 2009. PMID: 19275559 Review.
Molecular recognition models: a challenge to overcome.
Caceres RA, Pauli I, Timmers LF, de Azevedo WF Jr. Caceres RA, et al. Among authors: pauli i. Curr Drug Targets. 2008 Dec;9(12):1077-83. doi: 10.2174/138945008786949414. Curr Drug Targets. 2008. PMID: 19128218 Review.
In silico and in vitro: identifying new drugs.
Pauli I, Timmers LF, Caceres RA, Soares MB, de Azevedo WF Jr. Pauli I, et al. Curr Drug Targets. 2008 Dec;9(12):1054-61. doi: 10.2174/138945008786949397. Curr Drug Targets. 2008. PMID: 19128215 Review.
Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity.
Espinoza-Chávez RM, Oliveira Rezende Júnior C, de Souza ML, Pauli I, Valli M, Gomes Ferreira LL, Chelucci RC, Michelan-Duarte S, Krogh R, Romualdo da Silva FB, Cruz FC, de Oliveira AS, Andricopulo AD, Dias LC. Espinoza-Chávez RM, et al. Among authors: pauli i. Future Med Chem. 2024 Feb;16(3):253-269. doi: 10.4155/fmc-2023-0185. Epub 2024 Jan 9. Future Med Chem. 2024. PMID: 38193294
Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics.
Pauli I, Rezende CO Jr, Slafer BW, Dessoy MA, de Souza ML, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Krogh R, Michelan-Duarte S, Del Pintor RV, da Silva FBR, Cruz FC, Dias LC, Andricopulo AD. Pauli I, et al. Front Pharmacol. 2022 Jan 5;12:774069. doi: 10.3389/fphar.2021.774069. eCollection 2021. Front Pharmacol. 2022. PMID: 35069198 Free PMC article.
Chalcones and their B-aryl analogues as myeloperoxidase inhibitors: In silico, in vitro and ex vivo investigations.
Santos MBD, Carvalho Marques B, Miranda Ayusso G, Rocha Garcia MA, Chiquetto Paracatu L, Pauli I, Silva Bolzani V, Defini Andricopulo A, Farias Ximenes V, Zeraik ML, Regasini LO. Santos MBD, et al. Among authors: pauli i. Bioorg Chem. 2021 May;110:104773. doi: 10.1016/j.bioorg.2021.104773. Epub 2021 Mar 2. Bioorg Chem. 2021. PMID: 33744807
Molecular modeling as a tool for drug discovery.
Barcellos GB, Pauli I, Caceres RA, Timmers LF, Dias R, de Azevedo WF Jr. Barcellos GB, et al. Among authors: pauli i. Curr Drug Targets. 2008 Dec;9(12):1084-91. doi: 10.2174/138945008786949388. Curr Drug Targets. 2008. PMID: 19128219 Review.
20 results